Mesa LaboratoriesMLAB
MLAB
0
Funds holding %
of 7,398 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)
14% more repeat investments, than reductions
Existing positions increased: 58 | Existing positions reduced: 51
6% more capital invested
Capital invested by funds: $635M [Q3] → $673M (+$38.8M) [Q4]
3.53% more ownership
Funds ownership: 90.6% [Q3] → 94.13% (+3.53%) [Q4]
6% less funds holding
Funds holding: 166 [Q3] → 156 (-10) [Q4]
37% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 19
Research analyst outlook
We haven’t received any recent analyst ratings for MLAB.
Financial journalist opinion
Negative
Investors Business Daily
5 days ago
How Tariffs Are Rocking The 'Bubblegum And Shoestring' Medical Supply Chain
Tariff uncertainty has cast a pall over medical stocks. Re-shoring is possible, but expensive, leaving them in a "wait-and-see" pattern.
Positive
Zacks Investment Research
6 days ago
What Makes Mesa Labs (MLAB) a New Strong Buy Stock
Mesa Labs (MLAB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Positive
Zacks Investment Research
1 month ago
Why Mesa Labs (MLAB) Might be Well Poised for a Surge
Mesa Labs (MLAB) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Positive
Zacks Investment Research
1 month ago
Mesa Labs (MLAB) Q3 Earnings and Revenues Beat Estimates
Mesa Labs (MLAB) came out with quarterly earnings of $2.67 per share, beating the Zacks Consensus Estimate of $2.45 per share. This compares to earnings of $2.02 per share a year ago.
Neutral
GlobeNewsWire
1 month ago
Mesa Labs Announces Third Quarter Results
LAKEWOOD, Colo., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced results for its third fiscal quarter (“3Q25”) ended December 31, 2024 (amounts in thousands).
Neutral
GlobeNewsWire
2 months ago
Mesa Laboratories, Inc. to Announce Third Quarter Results on February 4, 2025
LAKEWOOD, Colo., Jan. 17, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) will issue a press release with financial results for the third quarter of fiscal year 2025 at approximately 8:00 A.M. Eastern time on Tuesday, February 4, 2025.
Neutral
GlobeNewsWire
2 months ago
MESA LABS DECLARES QUARTERLY DIVIDEND
LAKEWOOD, Colo., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on March 17, 2025, to shareholders of record at the close of business on February 28, 2025.
Negative
Zacks Investment Research
4 months ago
Mesa Labs (MLAB) Lags Q2 Earnings and Revenue Estimates
Mesa Labs (MLAB) came out with quarterly earnings of $2.45 per share, missing the Zacks Consensus Estimate of $2.48 per share. This compares to earnings of $1.91 per share a year ago.
Neutral
GlobeNewsWire
4 months ago
Mesa Labs Announces Second Quarter Results
LAKEWOOD, Colo., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced results for its second fiscal quarter (“2Q25”) ended September 30, 2024 (amounts in thousands).
Neutral
GlobeNewsWire
5 months ago
MESA LABS DECLARES QUARTERLY DIVIDEND
LAKEWOOD, Colo., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on December 16, 2024, to shareholders of record at the close of business on November 29, 2024.
Charts implemented using Lightweight Charts™